You have the power to help researchers better understand the lived experience of multiple sclerosis (MS), which has the potential to transform treatments. Together, we can change the future of MS.
Register to join our participant registry
With the assistance of a large, diverse pool of research study participants, we investigate novel interventions to help people with MS live their best lives. Participating in a research study can be an empowering and impactful opportunity and help accelerate breakthroughs in treatment. We’ll contact you about study enrollment opportunities for the condition(s) you specify.
volunteers are key research partners
- You are the expert in MS. No one understands MS better than those living with it every day.
- By working together, we can help shape the future of research. Your lived experience can help shape future treatments.
Participate in our current research
CBT FOR MS FATIGUE
This study will develop and pilot test three telehealth cognitive behavioral therapy (CBT) elements for fatigue in people with MS to maximize feasibility and acceptability. We seek to understand which component decreases MS fatigue the most.
- Participants will be randomly assigned one of three CBT components, and will complete four telehealth treatments, two online surveys, and an interview with study staff.
- Up to $60 total compensation provided.
- Contact us at (206) 598-0501 or msstudy@uw.edu to join.
CogDetect-MS
This study examines cognitive functioning in the daily lives of people with MS. We seek to gain new insights to measure cognitive functioning and to improve the health-related quality of life of people with MS.
- Participants will complete three in-person visits and three home-monitoring periods over two years. A 14-day home monitoring period follows each in-person visit.
- Up to $600 total compensation provided.
- Contact us at (206) 598-0501 or cogdetectms@uw.edu to join.
- Learn more here.
Your Safety is important
Study staff will discuss any risks involved in the studies in which you participate. Most of our studies pose minimal risk and all studies listed on this site have been reviewed and approved by an institutional review board (IRB), a group dedicated to protecting the welfare of human research participants.